Vaneltix Pharma, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) (NCT06394830) | Vaneltix Pharma, Inc. | 2024-12-13 |
| Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS (NCT05737121) | Vaneltix Pharma, Inc. | 2023-05-22 |
Track Vaneltix Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.